Search for: "Johnson and Price" Results 321 - 340 of 1,975
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Feb 2016, 9:30 pm by Dan Ernst
Johnson[:]I see NRA Counsel use my name, for basic[.] [read post]
5 Apr 2023, 6:15 am by Adam Levitin
Precisely one hour and thirty-nine minutes after the dismissal of the bankruptcy filing of LTL, Johnson & Johnson’s artificially created talc-liability subsidiary, the company was right back at it again with the filing of a new chapter 11 case in New Jersey, again assigned to Judge Kaplan. [read post]
26 May 2022, 7:00 am by Dan Farber
Prices in the UK market have closely tracked the EU. [read post]
12 Mar 2019, 4:00 am by John Willinsky
While researchers question why the TB patent pipeline is so constricted, the costs involved in the stalled patents, as well as the successful drug’s own development, may seem to warrant Johnson and Johnson’s pricing. [read post]
15 Oct 2015, 4:16 pm by admin
Johnson On October 9, 2015 Nordstom failed in its attempt to have the district court in its California’s Unfair Competition Law (UCL) (Cal. [read post]
29 Dec 2011, 8:14 am by Lovechilde
By Dave Johnson, cross-posted from Campaign for America's Future In November President Obama said, "enough is enough" to China's currency manipulations. [read post]
3 Nov 2010, 6:56 am by Bexis
  To borrow the political meme of the moment, the class complained the price of Mead Johnson’s formula was “2 damn high. [read post]
4 Jan 2010, 6:23 pm by Frank Pasquale
"We were really, really undervalued," said Brooke Johnson, the president of the Food Network. . . . [read post]
21 May 2007, 6:30 am
Daniels, Johanns and Johnson were later slammed with snippy ethanol questions from angry livestock owners, much to their dazed surprise. [read post]
9 Jun 2011, 6:00 am by Angela Herrington
 Ten days later, the agency approved a competing hepatitis C drug, Incivek, by Vertex Pharmaceuticals and Johnson & Johnson. [read post]
30 Mar 2020, 7:34 am by Deb Givens
  EU antitrust regulators have opened a full investigation into Johnson & Johnson’s acquisition of Takeda Pharmaceutical’s surgical patch product TachoSil, concerned that the deal could lead to reduced choice and higher prices for customers. [read post]
15 Jul 2010, 8:34 am by Josh Wright
The banks do not have monopoly pricing power in the traditional sense, and their market share – at the national level – is lower than what would trigger an antitrust investigation in the non-financial sectors. [read post]
26 Jun 2011, 11:00 am by J Robert Brown Jr.
In hindsight, these decisions look obvious but at the time, Judge Johnson paid a heavy price for them. [read post]
16 Jan 2014, 10:39 pm by Ben Reeve-Lewis
London Property Prices Planet Property informs us all this week about new research from the Said Business School of Oxford that explains why London’s house prices are always on the up. [read post]